Seeing Is Believing

Currently out of the existing stock ratings of Brandon Folkes, 193 are a BUY (91.04%), 19 are a HOLD (8.96%).
Analyst Brandon Folkes, carries an average stock price target met ratio of 31.82% that have a potential upside of 20.92% achieved within 225 days. Previously, Brandon Folkes worked at CANTOR FITZGERALD, GUGGENHEIM.
Brandon Folkes’s has documented 410 price targets and ratings displayed on 49 stocks. The coverage was on Healthcare, Energy sectors.
Most recent stock forecast was given on PYPD, PolyPid at 21-Jul-2026.
Analyst best performing recommendations are on ANIP (ANI PHARMACEUTICALS).
The best stock recommendation documented was for ANIP (ANI PHARMACEUTICALS) at 8/7/2025. The price target of $84 was fulfilled within 4 days with a profit of $14.99 (21.72%) receiving and performance score of 54.3.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$6
$0.41 (7.33%)
$8
4 years 5 months 5 days ago
(25-Feb-2022)
1/4 (25%)
$2.17 (44.83%)
281
Buy Since 09-Jan-2020
$5.6
$0.01 (0.18%)
$5.6
4 years 5 months 15 days ago
(15-Feb-2022)
2/3 (66.67%)
$0.04 (0.72%)
36
Hold Since 10-Nov-2021
$4.5
$-1.09 (-19.50%)
$4.5
4 years 6 months 9 days ago
(21-Jan-2022)
6/7 (85.71%)
$1.14 (33.93%)
152
Buy Since 14-Aug-2018
$6.25
$0.66 (11.81%)
$4.5
5 years 2 months 24 days ago
(06-May-2021)
2/3 (66.67%)
$3.07 (96.54%)
228
Buy Since 14-Oct-2015
$8
$2.41 (43.11%)
$21
6 years 8 months 17 days ago
(13-Nov-2019)
0/2 (0%)
$2 (33.33%)
Which stock is Brandon Folkes is most bullish on?
Which stock is Brandon Folkes is most reserved on?
What Year was the first public recommendation made by Brandon Folkes?